References
- KimSJFlachAJJampolLMNonsteroidal anti-inflammatory drugs in ophthalmologySurv Ophthalmol201055210813320159228
- Acular® LS [package insert]Irvine, CAAllergan, Inc2008
- Acular LS® [package insert]Irvine, CAAllergan, Inc1997
- DonnenfeldEDPerryHDWittpennJRSolomonRNattisAChouTPreoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curveJ Cataract Refract Surg20063291474148216931258
- PerryHDDonnenfeldEDAn update on the use of ophthalmic ketorolac tromethamine 0.4%Expert Opin Pharmacother2006719910716370927
- PriceFWJrPriceMOZehWDobbinsKPain reduction after laser in situ keratomileusis with ketorolac tromethamine ophthalmic solution 0.5%: a randomized, double-masked, placebo-controlled trialJ Refract Surg200218214014411934202
- PriceMOPriceFWEfficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgeryCurr Med Res Opin200420122015201915701218
- SandovalHPFérnandez de CastroLEVromanDTSolomonKDEvaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantationJ Ocul Pharmacol Ther200622425125716910866
- SolomonKDDonnenfeldEDRaizmanMSafety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patientsJ Cataract Refract Surg20043081653166015313287
- FlachAJJampolLMWeinbergDImprovement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamineAm J Ophthalmol199111255145191951587
- WaterburyLDFlachAJEfficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammationJ Ocul Pharmacol Ther200420434535215321029
- LingTLCombsDLOcular bioavailability and tissue distribution of [14C] ketorolac tromethamine in rabbitsJ Pharm Sci19877642892943598886
- HeierJSAwhCCBusbeeBGVitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%Retina20092991310131319934822
- KyyronenKUrttiAImproved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrineInvest Ophthalmol Vis Sci1990319182718332211028
- PaughJRChatelierRCHuffJWOcular residence time of carboxymethylcellulose solutionsAdv Exp Med Biol19984387617679634965
- SasakiHYamamuraKMukaiTPharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicleBiol Pharm Bull200023111352135611085365
- GarrettQSimmonsPAXuSCarboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healingInvest Ophthalmol Vis Sci20074841559156717389485
- KatzungBGKatzungBGBasic principlesBasic and Clinical Pharmacology6th edLondon, UKPrentice Hall International199518
- SasakiHNaganoTYamamuraKNishidaKNakamuraJOphthalmic preservatives as absorption promoters for ocular drug deliveryJ Pharm Pharmacol19954797037078583378
- MadhuCRixPJShackletonMJNguyenTGTang-LiuDDEffect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbitsJ Pharm Sci19968544154188901080
- MalhotraMMajumdarDKEffect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamineIndian J Exp Biol200240555555912622201
- DonnenfeldENichaminLDHardtenDRTwice-daily, preservative- free ketorolac 0.45% for treatment of inflammation and pain following cataract surgeryAm J Ophthalmol2010in press
- Acuvail® [package insert]Irvine, CAAllergan, Inc2009
- EisenSAMillerDKWoodwardRSSpitznagelEPrzybeckTRThe effect of prescribed daily dose frequency on patient medication complianceArch Intern Med19901509188118842102668
- KruseWEggert-KruseWRampmaierJRunnebaumBWeberEDosage frequency and drug-compliance behaviour – a comparative study on compliance with a medication to be taken twice or four times dailyEur J Clin Pharmacol19914165895921815972